Author ORCID Identifier

http://orcid.org/0000-0001-6945-2521

Document Type

Other

Disciplines

Cell biology,, Biochemistry and molecular biology

Publication Details

School of Food Science & Environmental Health (FSEH) research event 2024 (TU Dublin)

doi:10.21427/xs9d-en93

Abstract

Androgen receptor (AR)-targeted therapy remains the gold standard strategy for the treatment of advanced prostate cancer. Several compounds of Indane derivatives have been reported to exhibit significant AR antagonist capabilities, starting at a concentration as low as 0.1 μM. However, an anti-prostate cancer lead molecule derived from Indane-related scaffold remains elusive. The project will investigate the interaction of novel bioactive indane scaffolds as androgen receptor antagonists through in silico and in vitro screening to complete the hit-to-lead, while also investigating potential drug delivery and drug activation/sensitisation mechanisms using a combination of colloid nanomaterial and cold atmospheric plasma to target AR-independent, recurrent prostate cancer.

DOI

https://doi.org/10.21427/xs9d-en93

Creative Commons License

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.


Share

COinS